Infant Rhesus Macaque Brain α-Tocopherol Stereoisomer Profile Is Differentially Impacted by the Source of α-Tocopherol in Infant Formula.
Macaca mulatta
RRR-α-tocopherol
all rac-α-tocopherol
breast milk
infant
lactation
rhesus macaque
stereoisomer
vitamin E
α-tocopherol
Journal
The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
received:
13
01
2020
revised:
17
04
2020
accepted:
27
05
2020
pubmed:
3
7
2020
medline:
17
12
2020
entrez:
3
7
2020
Statut:
ppublish
Résumé
α-Tocopherol (αT) in its natural form [2'R, 4'R, 8'R αT (RRR-αT)] is more bioactive than synthetic α-tocopherol (all rac-αT). All rac-αT is widely used in infant formulas, but its accretion in formula-fed infant brain is unknown. We sought to compare αT and stereoisomer status in infant rhesus macaques (Macaca mulatta) fed infant formula (RRR-αT or all rac-αT) with a reference group fed a mixed diet of breast milk and maternal diet. From 1 d after birth until 6 mo of age, infants (n = 23) were either nursery reared and exclusively fed 1 of 2 formulas by staff personnel or were community housed with their mothers and consumed a mixed reference diet of breast milk (69 mL/d at 6 mo) transitioning to monkey diet at ∼2 mo (MF; n = 8). Formulas contained either 21 μmol RRR-αT/L (NAT-F; n = 8) or 30 μmol all rac-αT/L (SYN-F; n = 7). Total αT and αT stereoisomers were analyzed in breast milk at 2, 4, and 6 mo and in monkey plasma and liver and 6 brain regions at 6 mo of age. α-Tocopherol transfer protein (α-TTP), lipoprotein αT, and urinary α-carboxyethyl-hydroxychroman (α-CEHC) were measured. One-way ANOVA with Tukey's post-hoc test was used for analysis. At study termination, plasma, liver, lipoprotein, and brain total αT did not differ between groups. However, the NAT-F-fed group had higher RRR-αT than the SYN-F-fed group (P < 0.01) and the MF group (P < 0.0001) in plasma (1.7- and 2.7-fold) and brain (1.5- and 2.5-fold). Synthetic αT 2R stereoisomers (SYNTH-2R) were generally 3- and 7-fold lower in brain regions of the NAT-F group compared with those of the SYN-F and MF groups (P < 0.05). SYNTH-2R stereoisomers were 2-fold higher in MF than SYN-F (P < 0.0001). The plasma percentage of SYNTH-2R was negatively correlated with the brain percentage of RRR-αT (r = -0.99, P < 0.0001). Brain αT profiles were not explained by α-TTP mRNA or protein expression. Urine α-CEHC was 3 times higher in the NAT-F than in the MF group (P < 0.01). Consumption of infant formulas with natural (NAT-F) compared with synthetic (SYN-F) αT differentially impacted brain αT stereoisomer profiles in infant rhesus macaques. Future studies should assess the functional implications of αT stereoisomer profiles on brain health.
Sections du résumé
BACKGROUND
α-Tocopherol (αT) in its natural form [2'R, 4'R, 8'R αT (RRR-αT)] is more bioactive than synthetic α-tocopherol (all rac-αT). All rac-αT is widely used in infant formulas, but its accretion in formula-fed infant brain is unknown.
OBJECTIVE
We sought to compare αT and stereoisomer status in infant rhesus macaques (Macaca mulatta) fed infant formula (RRR-αT or all rac-αT) with a reference group fed a mixed diet of breast milk and maternal diet.
METHODS
From 1 d after birth until 6 mo of age, infants (n = 23) were either nursery reared and exclusively fed 1 of 2 formulas by staff personnel or were community housed with their mothers and consumed a mixed reference diet of breast milk (69 mL/d at 6 mo) transitioning to monkey diet at ∼2 mo (MF; n = 8). Formulas contained either 21 μmol RRR-αT/L (NAT-F; n = 8) or 30 μmol all rac-αT/L (SYN-F; n = 7). Total αT and αT stereoisomers were analyzed in breast milk at 2, 4, and 6 mo and in monkey plasma and liver and 6 brain regions at 6 mo of age. α-Tocopherol transfer protein (α-TTP), lipoprotein αT, and urinary α-carboxyethyl-hydroxychroman (α-CEHC) were measured. One-way ANOVA with Tukey's post-hoc test was used for analysis.
RESULTS
At study termination, plasma, liver, lipoprotein, and brain total αT did not differ between groups. However, the NAT-F-fed group had higher RRR-αT than the SYN-F-fed group (P < 0.01) and the MF group (P < 0.0001) in plasma (1.7- and 2.7-fold) and brain (1.5- and 2.5-fold). Synthetic αT 2R stereoisomers (SYNTH-2R) were generally 3- and 7-fold lower in brain regions of the NAT-F group compared with those of the SYN-F and MF groups (P < 0.05). SYNTH-2R stereoisomers were 2-fold higher in MF than SYN-F (P < 0.0001). The plasma percentage of SYNTH-2R was negatively correlated with the brain percentage of RRR-αT (r = -0.99, P < 0.0001). Brain αT profiles were not explained by α-TTP mRNA or protein expression. Urine α-CEHC was 3 times higher in the NAT-F than in the MF group (P < 0.01).
CONCLUSIONS
Consumption of infant formulas with natural (NAT-F) compared with synthetic (SYN-F) αT differentially impacted brain αT stereoisomer profiles in infant rhesus macaques. Future studies should assess the functional implications of αT stereoisomer profiles on brain health.
Identifiants
pubmed: 32614402
pii: S0022-3166(22)02301-X
doi: 10.1093/jn/nxaa174
pmc: PMC7467853
doi:
Substances chimiques
Carrier Proteins
0
Chromans
0
Propionates
0
alpha-tocopherol transfer protein
0
2,5,7,8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman
4072-32-6
alpha-Tocopherol
H4N855PNZ1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2305-2313Subventions
Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © The Author(s) on behalf of the American Society for Nutrition 2020.
Références
Animal. 2019 Sep;13(9):1874-1882
pubmed: 30587272
FASEB J. 1999 Jul;13(10):1145-55
pubmed: 10385606
Br J Nutr. 2016 Jul;116(1):126-31
pubmed: 27181635
J Pediatr Gastroenterol Nutr. 2017 Apr;64(4):616-623
pubmed: 27478896
Br J Nutr. 2018 Dec;120(12):1332-1337
pubmed: 30328404
Ann Nutr Metab. 2012;61(3):207-12
pubmed: 23183290
Int J Vitam Nutr Res. 1982;52(3):351-70
pubmed: 7174231
Free Radic Biol Med. 2013 Dec;65:1291-1299
pubmed: 24075893
J Anim Sci. 2019 Mar 1;97(3):1222-1233
pubmed: 30624663
J Nutr. 2020 May 1;150(5):1031-1040
pubmed: 31883016
J Nutr. 2008 Feb;138(2):323-31
pubmed: 18203899
Biochim Biophys Acta. 1984 Feb 9;792(2):118-22
pubmed: 6696923
J Nutr. 2002 Jun;132(6):1258-64
pubmed: 12042443
J Lipid Res. 1990 Apr;31(4):675-85
pubmed: 2351872
J Nutr. 2016 Sep;146(9):1677-83
pubmed: 27511933
Neurochem Res. 1989 Dec;14(12):1209-12
pubmed: 2534160
J Nutr. 2018 Jan 1;148(1):31-39
pubmed: 29378053
Arch Biochem Biophys. 2010 Mar 1;495(1):49-55
pubmed: 20026030
Br J Nutr. 2006 Mar;95(3):477-87
pubmed: 16512933
Ann N Y Acad Sci. 2004 Dec;1031:109-26
pubmed: 15753139
Pediatr Res. 2014 Oct;76(4):394-400
pubmed: 25116230
Annu Rev Nutr. 2007;27:347-62
pubmed: 17439363
J Nutr. 1996 Oct;126(10):2539-49
pubmed: 8857515
Nutr Neurosci. 2005 Feb;8(1):21-9
pubmed: 15909764
Am J Clin Nutr. 2002 Mar;75(3):555-60
pubmed: 11864863
J Neurochem. 1984 Feb;42(2):554-8
pubmed: 6693887
J Clin Invest. 1994 Jun;93(6):2764-7
pubmed: 8201015
Pediatr Res. 1984 Sep;18(9):911-4
pubmed: 6483513
J Pediatr. 1992 Apr;120(4 Pt 2):S109-16
pubmed: 1560323
J Nutr Health Aging. 2004;8(3):156-62
pubmed: 15129301
Rev Paul Pediatr. 2017 Apr-Jun;35(2):158-164
pubmed: 28977333
Free Radic Biol Med. 2003 Dec 1;35(11):1343-54
pubmed: 14642382
Am J Clin Nutr. 1998 Apr;67(4):669-84
pubmed: 9537614
J Pediatr (Rio J). 2014 Sep-Oct;90(5):440-8
pubmed: 24953721
Arch Biochem Biophys. 2018 Sep 15;654:97-104
pubmed: 30003875
Curr Dev Nutr. 2018 Jun 15;2(8):nzy055
pubmed: 30140787
J Anim Sci. 2002 Mar;80(3):702-7
pubmed: 11890405
J Aging Res. 2013;2013:951786
pubmed: 23840953
N Engl J Med. 1985 Dec 19;313(25):1580-6
pubmed: 4069170
Neurobiol Dis. 2015 Dec;84:78-83
pubmed: 25913028